Hers vs Noom compared: program models, medication pathways, pricing tiers, and eligibility criteria. Fair editorial context for readers researching Hers and Noom.

Hers vs Medvi compared: subscription pricing, clinical oversight, compounded-pharmacy pathway, and the genetic variable. Fair editorial context for readers.

Hers vs Ro compared: subscription pricing, clinical oversight, compounded-pharmacy pathway, and the genetic variable. Fair editorial context for readers.

Explore Hers vs Noom: subscription pricing, clinical oversight, compounded-pharmacy pathway, and the genetic variable.

Hers vs Hims compared: subscription pricing, clinical oversight, compounded-pharmacy pathway, and the genetic variable. Fair editorial context for readers.

An editorial review of Hers — program models, medication pathways, pricing tiers, and eligibility criteria. Independent; PlexusDx has no commercial relationship.

An editorial review of Hers — pricing structure, eligibility discounts, and total out-of-pocket expectations.

An editorial review of Hers — business model, clinical structure, and how the program compares to PlexusDx Weight Management Protocols.

A fair look at Hers, covering program overview, medication approach, pricing, and the genetic variable the brand does not address. An independent editorial.

Hers reviewed: program overview, medication approach, pricing, and the genetic variable the brand does not address. Fair editorial context for readers.

Hers reviewed: monthly pricing, subscription tiers, medication costs, and what's included. Fair editorial context for readers researching this area.

Explore Hers: business model, clinical structure, and how the program compares to PlexusDx Weight Management Protocols. Independent editorial review of HERS.

An editorial review of Hers: program structure, compounded-pharmacy pathway, pricing, and safety considerations. Independent editorial review of HERS.

An editorial review of Hers — program structure, compounded-pharmacy pathway, pricing, and safety considerations. Independent review of HERS.

An editorial review of Hers — program overview, medication approach, pricing, and the genetic variable the brand does not address.

An editorial review of Hers, covering how the GLP-1 program works, eligibility, and how it compares to PlexusDx Weight Management Protocols.

Hers reviewed: program model, medication options, eligibility, pricing, and editorial context. Fair editorial context for readers researching HERS.

Hers accepts HSA/FSA via reimbursement (pay with regular card, submit receipt). PlexusDx accepts HSA/FSA card payment at checkout where your plan permits, with no membership fee — protocols from $129/mo, all 50 states.

Eight month-to-month GLP-1 providers compared against PlexusDx Weight Management Protocols on real annual cost, hidden membership fees, intro-price cliffs, and genetic baseline. PlexusDx Microdose at $129/mo flat, Semaglutide Injection $179–$229, Tirzepatide Injection $229–$309, GLP-Squared $179–$325 — all cash-pay, no membership.

Which Wegovy providers actually let you swipe your FSA card at checkout vs. file for reimbursement? NovoCare Pharmacy and LifeMD verified for direct-card payment; Hims, Hers, and Ro are reimbursement-first. Plus what to do when your FSA balance runs out and PlexusDx Semaglutide Injection at $179–$229/mo becomes the flat cash-pay reframe.

MEDVi vs Hers vs PlexusDx in 2026: real annual cost math, compounded vs FDA-approved branded medication source, tirzepatide availability across all three, cancellation and refund policy differences, and where the Precision Peptide Genetic Test fits when GLP-1 response varies by GLP1R, GIPR, FTO, MC4R, and TCF7L2 variants.

Florida residents can legally start GLP-1 telehealth in days under Statute §456.47. We compare MEDVi, Ro, Walgreens, and the PlexusDx Microdose GLP-1 Protocol from $129/mo — with a genetic baseline option no other Florida provider offers.